Abstract
Angiogenesis is defined as the production of new blood vessels from pre-existing blood vessels. It is a carefully controlled process that occurs in a healthy individual only under specific conditions at specific times, such as during embryogenesis, wound healing, ovulation and menses. At other times, the vasculature is extremely stable, with very low rates of endothelial cell turnover and little production of new vessels [1]. However, there are pathological conditions in which angiogenesis occurs, examples being cancer, arthritis, ocular diseases, psoriasis [2–4]. In fact, the hypothesis has been proposed that many of these diseases depend on the new vasculature to provide a basis for their proliferation [5–7]. Thus, inhibition of angiogenesis is proposed to be a potential therapeutic approach to chronic proliferative diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fan TP, Jaggar R, Bicknell R (1995) Controlling the vasculature: angiogenesis, anti-
angiogenesis and vascular targeting of gene therapy. Trends Pharmacol Sci 16: 57–66
Polverini PJ (1995) The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 6: 230–247
Chung SK, Ng A, Min HY, Strattonthomas J, Rosenberg S, Shuman M, Hwang DG (1995) Inhibition of basic fibroblast growth factor-induced corneal angiogenesis by a urokinase plasminogen-activator receptor antagonist. Invest Ophthal Visual Sci 36: S30
Folkman J, Brem H (1992) Angiogenesis and inflammation. In: JI Gallin, IM Goldstein, R Snyderman (eds): Inflammation: Basic principles and clinical correlates, Second edition. Raven Press Ltd, New York, 821–839
Folkman J (1972) Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175: 409–416
Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267 (16): 10931–10934
Folkman J (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol 3 (2): 65–71
Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD (1997) The co-dependence of angiogenesis and chronic inflammation. FASEB J 11: 457–465
Polverini PJ (1997) Role of the macrophage in angiogenesis-dependent diseases. EXS 79: 11–28
Auerbach W, Auerbach R (1994) Angiogenesis inhibition: A review. Pharmacol Ther 63: 265–311
Okamura K, Morimoto A, Hamanaka R, Ono M, Kohno K, Uchida Y, Kuwano M (1992) A model system for tumor angiogenesis: involvement of transforming growth factor-alpha in tube formation of human microvascular endothelial cells induced by esophageal cancer cells. Biochem Biophys Res Comm 186: 1471–1479
Colville Nash PR, Willoughby DA (1997) Growth factors in angiogenesis: current interest and therapeutic potential. Mol Med Today 3: 14–23
Folkman J (1997) Angiogenesis and angiogenesis inhibition: an overview. EXS 79: 1–8
Iruela-Arispe ML, Dvorak HF (1997) Angiogenesis: a dynamic balance of stimulators and inhibitors. Thromb Haemost 78: 672–677
Villaschi S, Nicosia RF (1993) Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. Am J Pathol 143: 181–190
Nicosia RF, Villaschi S (1995) Rat aortic smooth-muscle cells become pericyte-like cells during angiogenesis in vitro. Faseb J 9: A 587
Cockerill GW, Gamble JR, Vadas MA (1995) Angiogenesis: Models and modulators. Int Rev Cytology 159: 113–160
Colville-Nash PR, Seed MP (1993) The current state of angiostatic therapy, with special reference to rheumatoid arthritis. Curr Opin Invest Drugs 2: 763–813
Auerbach R, Auerbach W, Polakowski I (1991) Assays for angiogenesis: a review. Pharmacol Ther 51: 1–11
Folkman J (1974) Proceedings: Tumor angiogenesis factor. Cancer Res 34: 2109–2113
Nguyen M, Shing Y, Folkman J (1994) Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res 47: 31–40
Wilting J, Christ B, Bokeloh M (1991) A modified chorioallantoic membrane (CAM) assay for qualitative and quantitative study of growth factors. Studies on the effects of carriers, PBS, angiogenin, and bFGF. Anat Embryol Berl 183: 259–271
Maragoudakis ME, Haralabopoulos GC, Tsopanoglou NE, Pipili Synetos E (1995) Validation of collagenous protein synthesis as an index for angiogenesis with the use of morphological methods. Microvasc Res 50: 215–222
Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B, Alitalo K, Wilting J (1997) VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188: 96–109
Tsopanoglou NE, Pipili Synetos E, Maragoudakis ME (1993) Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am J Physiol 264: C1302 — C1307
Anand Apte B, Pepper MS, Voest E, Montesano R, Olsen B, Murphy G, Apte SS, Zetter B (1997) Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci 38: 817–823
Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA (1994) Integrin avb3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157–1164
Kusaka M, Sudo K, Fujita T, Marui S, Itoh F, Ingber D, Folkman J (1991) Potent antiJames D. Winkler et al. angiogenic action of AGM-1470: comparison to the fumagilliam parent. Biochem Biophys Res Commun 174: 1070–1076
Tsopanoglou NE, Haralabopoulos GC, Maragoudakis ME (1994) Opposing effects on modulation of angiogenesis by protein kinase C and cAMP-mediated pathways. J Vasc Res 31: 195–204
Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 67: 519–528
Haralabopoulos GC, Grant DS, Kleinman HK, Maragoudakis ME (1997) Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am J Physiol 273: C239 — C245
Angiolillo AL, Kanegane H, Sgadari C, Reaman GH, Tosato G (1997) Interleukin-15 promotes angiogenesis in vivo. Biochem Biophys Res Commun 233: 231–237
Montrucchio G, Lupia E, De Martino A, Battaglia E, Arese M, Tizzani A, Bussolino F, Camussi G (1997) Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha. Am J Pathol 151: 557–563
Joseph IB, Vukanovic J, Isaacs JT (1996) Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents. Cancer Res 56: 3404–3408
Lupia E, Montrucchio G, Battaglia E, Modena V, Camussi G (1996) Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis. Eur J Immunol 26: 1690–1694
Ito Y, Iwamoto Y, Tanaka K, Okuyama K, Sugioka Y (1996) A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo. Int J Cancer 67: 148–152
Plunkett ML, Hailey JA (1990) An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate. Lab Invest 62: 510–517
Hoffmann J, Schirner M, Menrad A, Schneider MR (1997) A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells. Cancer Res 57: 3847–3851
Kimura M, Amemiya K, Yamada T, Suzuki J (1986) Quantitative method for measuring adjuvant-induced granuloma angiogenesis in insulin-treated diabetic mice. J Pharmacobio-Dyn 9: 442–446
Colville-Nash PR, Alam CAS, Appleton I, Browne JR, Seed MP, Willoughby DA (1995) The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J Pharmacol Exp Ther 274: 1463–1472
Andrade SP, Fan TP, Lewis GP (1987) Quantitative in vivo studies on angiogenesis in a rat sponge model. Br J Exp Pathol 68: 755–766
Hu DE, Hiley CR, Smither RL, Gresham GA, Fan TP (1995) Correlation of 133Xe clearance, blood flow and histology in the rat sponge model for angiogenesis. Further studies with angiogenic modifiers. Lab Invest 72: 601–610
Colville-Nash PR, El-Ghazaly M, Willoughby DA (1993) The use of angiostatic steroids to inhibit cartilidge destruction in an in vivo model of granuloma mediated cartilidge destruction. Agents and Actions 38: 126–134
Hori Y, Hu DE, Yasui K, Smither RL, Gresham GA, Fan TP (1996) Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants. Br J Pharmacol 118: 1584–1591
Jackson JR, Bolognese B, Hillegass L, Kassis S, Adams J, Griswold DE, Winkler JD (1998) Pharmacological effects of SB 220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther 284: 687–692
Jackson JR, Bolognese B, Hubbard WC, Marshall LA, Winkler JD (1998) Platelet-activating factor derived from 14 kDa phospholipase A2 contributes to inflammatory angiogenesis. Biochem Biophys Acta 1392: 145–152
Appleton I, Tomlinson A, Colville-Nash PR, Willoughby DA (1993) Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Lab Invest 69: 405–414
Kimura M, Suzuki J, Amemiya K (1985) Mouse granuloma pouch induced by Freund’s complete adjuvant with croton oil. J Pharmacobio-Dyn 8: 393–400
Gimbrone MA,Jr., Cotran RS, Leapman SB, Folkman J (1974) Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst 52: 413–427
Fournier GA, Lutty GA, Watt S, Fenselau A, Patz A (1981) A corneal micropocket assay for angiogenesis in the rat eye. Invest Ophthalmol Vis Sci 21: 351–354
Muthukkaruppan V, Auerbach R (1979) Angiogenesis in the mouse cornea. Science 205: 1416–1418
Galardy RE, Grobelny D, Foellmer HG, Fernandez LA (1994) Inhibition of angiogenesis by the matrix metalloprotease inhibitor N42R-2-(hydroxamidocarbonymethyl)-4methylpentanoyl)]-L-trypto phan methylamide. Cancer Res 54: 4715–4718
BenEzra D, Griffin BW, Maftzir G, Aharonov 0 (1993) Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide. Invest Ophthalmol Vis Sci 34: 3601–3608
Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D’Amato RJ (1996) A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 37: 1625–1632
BenEzra D, Maftzir G (1996) Antibodies to IL-1 and TNF-alpha but not to bFGF or VEGF inhibit angiogenesis. Invest Ophthalmol Vis Sci 37: 4664
Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA (1995) Definition of 2 angiogenic pathways by distinct alpha(v) integrins. Science 270: 1500–1502
Pettet G, Chaplain MA, McElwain DL, Byrne HM (1996) On the role of angiogenesis in wound healing. Proc R Soc Lond B Biol Sci 263: 1487–1493
Sephel GC, Kennedy R, Kudravi S (1996) Expression of capillary basement membrane components during sequential phases of wound angiogenesis. Matrix Biol 15: 263–279
Takenaka H, Kishimoto S, Tooyama I, Kimura H, Yasuno H (1997) Protein expression of fibroblast growth factor receptor-1 in keratinocytes during wound healing in rat skin. J Invest Dermatol 109: 108–112
Arnold F, West DC (1991) Angiogenesis in wound healing. Pharmacol Ther 52 (3): 407–422
Lees VC, Fan TP (1994) A freeze-injured skin graft model for the quantitative study of basic fibroblast growth factor and other promoters of angiogenesis in wound healing. Br J Plast Surg 47: 349–359
Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG (1997) Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81: 567–574
Okumura M, Okuda T, Okamoto T, Nakamura T, Yajima M (1996) Enhanced angiogenesis and granulation tissue formation by basic fibroblast growth factor in healing-impaired animals. Arzneimittelforschung 46: 1021–1026
Christofidou-Solomidou M, Bridges M, Murphy GF, Albelda SM, DeLisser HM (1997) Expression and function of endothelial cell alpha IT integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras. Am J Pathol 151: 975–983
Dellian M, Witwer BP, Salehi HA, Yuan F, Jain RK (1996) Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am J Pathol 149: 59–71
Torres Filho IP, Hartley Asp B, Borgstrom P (1995) Quantitative angiogenesis in a syngeneic tumor spheroid model. Microvasc Res 49: 212–226
Lin P, Polverini P, Dewhirst M, Shan S, Rao PS, Peters K (1997) Inhibition of tumor angiogenesis using a soluble receptor established a role for Tie2 in pathologic vascular growth. J Clin Invest 100: 2072–2078
Norrby K (1992) On the quantitative rat mesenteric-window angiogenesis assay. EXS 61: 282–286
Norrby K (1996) Vascular endothelial growth factor and de novo mammalian angiogenesis. Microvasc Res 51: 153–163
Norrby K (1996) Interleukin-8 and de novo mammalian angiogenesis. Cell Prolif 29: 315–323
Norrby K (1997) Interleukin-1-alpha and de novo mammalian angiogenesis. Microvasc Res 54: 58–64
Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S (1997) Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 79: 206–213
Seed MP, Brown JR, Freemantle CN, Papworth JL, Colville Nash PR, Willis D, Somerville KW, Asculai S, Willoughby DA (1997) The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan. Cancer Res 57: 1625–1629
Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555–557
O’Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277–285
Borgstrom P, Torres Filho IP, Hartley Asp B (1995) Inhibition of angiogenesis and metastases of the Lewis-lung cell carcinoma by the quinoline-3-carboxamide, Linomide. Anticancer Res 15: 719–728
O’Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315–328
Taraboletti G, Garofalo A, Belotti D, Drudis T, Borsotti P, Scanziani E, Brown PD, Giavazzi R (1995) Inhibition of angiogenesis and murine hemangioma growth by Batimastat, a synthetic inhibitor of matric metalloproteinases. J Nall Cancer Inst 87: 293–298
Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS, Ferrara N (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362: 841–844
Boehm T, Folkman J, Browder T, O’Reilly MS (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390: 404–407
Neeman M, Abramovitch R, Schiffenbauer YS, Tempel C (1997) Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int J Exp Pathol 78: 57–70
Magovern CJ, Mack CA, Zhang J, Rosengart TK, Isom OW, Crystal RG (1997) Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. Hum Gene Ther 8: 215–227
Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM (1995) Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 21: 314–325
Oliver SJ, Banquerigo ML, Brahn E (1994) Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM- 1470, and a microtubule stabilizer, taxol. Cell Immunol 157: 291–299
Peacock DJ, Banquerigo ML, Brahn E (1995) A novel angiogenesis inhibitor suppresses rat adjuvant arthritis. Cell Immunol 160: 178–184
Griffith EC, Su Z, Turk BE, Chen S, Chang YH, Wu Z, Biemann K, Liu JO (1997) Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem Biol 4: 461–471
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
Winkler, J.D., Jackson, J.R., Fan, TP., Seed, M.P. (1999). Angiogenesis. In: Morgan, D.W., Marshall, L.A. (eds) In Vivo Models of Inflammation. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7775-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7775-6_4
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-7777-0
Online ISBN: 978-3-0348-7775-6
eBook Packages: Springer Book Archive